ITMCTR2000003831
Not yet recruiting
Phase 1
Clinical study on reducing the malignant risk of residual lung GGN with Jiawei Xiaolong pill based on AI image judgment Technology
onghua Hospital Shanghai University of Traditional Chinese Medicine0 sitesTBD
ConditionsGround glass nodule of lung
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Ground glass nodule of lung
- Sponsor
- onghua Hospital Shanghai University of Traditional Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. lung surgery was performed, postoperative pathology was cancer, residual ground glass nodules, ground glass nodules met the diagnostic criteria of Western medicine, CT imaging showed ground glass nodules, the maximum diameter of nodules was less than 8 mm;
- •2\. TCM syndrome differentiation belongs to liver stagnation and qi stagnation, spleen deficiency and phlegm dampness syndrome;
- •3\. Aged 25 to 80 years old;
- •4\. the course of oral Chinese medicine in outpatient department was more than 12 months, and informed consent was signed.
Exclusion Criteria
- •1\. in the process of clinical study, some complications and complications occurred, which affected the efficacy and safety judgment;
- •2\. the subjects had poor compliance and could not continue to cooperate to complete the 12\-month course of treatment;
- •3\. serious adverse reactions occurred and it was not suitable to continue the trial;
- •4\. the subjects asked to withdraw from the trial;
- •5\. For various reasons, the patient is unwilling to accept traditional Chinese medicine treatment;
- •6\. The patients underwent the operation of ground glass nodule again.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study for reducing the risk of progress of idiopathic osteonecrosis of the femoral head (ION) by teriparatide treatmentJPRN-UMIN000009610Asahikawa Medical University50
Completed
Not Applicable
The study to reduce the complications associated with BIS electrodesPatients, who are scheduled for elective surgery under general anesthesia with BIS monitoring.JPRN-UMIN000023717Department of Anesthesiology and Resuscitology, Shinshu University School of Medicine40
Not yet recruiting
Not Applicable
A randomized, controlled , double-blind clinical study on the prevention and treatment of peripheral neurotoxicity of oxaliplatin by Danggui Sini granuleITMCTR2000004124Jiangsu Province Hospital on Integration Chinese and Western Medicine
Active, not recruiting
Phase 1
Study on the ability of zoledronic acid to prevent worsening of radiographs of hands and feet of patients with rheumatoid arthritis diagnosed less than 2 years ago and who have few symptoms in their joints by making treatment with the drugs commonly used for the management of disease.Rheumatoid arthritisMedDRA version: 16.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2013-005001-31-ESDra. Carmen Gómez Vaquero (Servicio de Reumatología del Hospital Universiari de Bellvitge - Idibell)
Not yet recruiting
Phase 1
Clinical study for the prevention and treatment of rheumatoid arthritis by Modified Hua-Yu Qiang-Shen Tong-Bi DecoctioITMCTR2000004037Guangdong Provincial Hospital of Chinese Medicine